{"transactions":[{"id":4636033,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":30799,"kind":"person","name":"Halladay Benjamin","position":1,"cik":"0001953943","reported_name":"Halladay Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit (RSU)","published_at":"2026-10-06T20:15:13.000Z","date":"2026-10-05","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one share of the issuer's common stock at settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs will vest as to 1/4 of the total award on each of October 5, 2027, October 5, 2028, October 5, 2029 and October 5, 2030 subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":200000,"derivative":{"expiration_date":"2030-10-05","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001953943-26-000004","document":"form4-10062026_081008.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1953943/000195394326000004/form4-10062026_081008.xml","form_type":"4"}},{"id":4636032,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":30799,"kind":"person","name":"Halladay Benjamin","position":1,"cik":"0001953943","reported_name":"Halladay Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-10-06T20:15:13.000Z","date":"2026-10-05","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest as to 1/4 of the total award on the first anniversary of October 5, 2026, and thereafter in substantially equal monthly installments over 36 months, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":200000,"derivative":{"exercise_price":7.01,"expiration_date":"2036-10-05","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001953943-26-000004","document":"form4-10062026_081008.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1953943/000195394326000004/form4-10062026_081008.xml","form_type":"4"}},{"id":679283,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":21010,"kind":"person","name":"Stewart Richard Alistair","position":1,"cik":"0001713369","reported_name":"Stewart Richard Alistair","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-21T20:30:07.000Z","date":"2026-08-19","kind":"sale","planned":false,"acquired":false,"shares":20626,"price":8.493,"value":175176.618,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $8.4536 to $8.52 per share, inclusive.  The reporting person hereby undertakes to provide to the Issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":208249,"source":{"system":"sec-edgar","filing":"0001193125-26-361182","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/949858/000119312526361182/ownership.xml","form_type":"4"}},{"id":701657,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":28095,"kind":"person","name":"Sellig Thomas","position":1,"cik":"0001969416","reported_name":"Sellig Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit (RSU)","published_at":"2026-07-29T21:26:28.000Z","date":"2026-07-27","kind":"grant","planned":false,"acquired":true,"shares":16700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock at settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the terms of the RSU, the shares underlying the RSU vest 100% on the earlier of July 27, 2027 or the date immediately prior to the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's provision of service to the Issuer on the vesting date."}],"balance_after":16700,"derivative":{"expiration_date":"2036-07-27","underlying":"Common Stock","underlying_shares":16700},"source":{"system":"sec-edgar","filing":"0001193125-26-324262","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/949858/000119312526324262/ownership.xml","form_type":"4"}},{"id":701656,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":28095,"kind":"person","name":"Sellig Thomas","position":1,"cik":"0001969416","reported_name":"Sellig Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-07-29T21:26:28.000Z","date":"2026-07-27","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest 100% on the earlier of July 27, 2027 or the date immediately prior to the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's provision of service to the Issuer on the vesting date."}],"balance_after":25000,"derivative":{"exercise_price":6.18,"expiration_date":"2036-07-27","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001193125-26-324262","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/949858/000119312526324262/ownership.xml","form_type":"4"}},{"id":701652,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":28093,"kind":"person","name":"Martin Christopher Nathan","position":1,"cik":"0002097992","reported_name":"Martin Christopher Nathan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit (RSU)","published_at":"2026-07-29T21:24:15.000Z","date":"2026-07-27","kind":"grant","planned":false,"acquired":true,"shares":16700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock at settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the terms of the RSU, the shares underlying the RSU vest 100% on the earlier of July 27, 2027 or the date immediately prior to the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's provision of service to the Issuer on the vesting date."}],"balance_after":16700,"derivative":{"expiration_date":"2036-07-27","underlying":"Common Stock","underlying_shares":16700},"source":{"system":"sec-edgar","filing":"0001193125-26-324256","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/949858/000119312526324256/ownership.xml","form_type":"4"}},{"id":701651,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":28093,"kind":"person","name":"Martin Christopher Nathan","position":1,"cik":"0002097992","reported_name":"Martin Christopher Nathan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-07-29T21:24:15.000Z","date":"2026-07-27","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest 100% on the earlier of July 27, 2027 or the date immediately prior to the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's provision of service to the Issuer on the vesting date."}],"balance_after":25000,"derivative":{"exercise_price":6.18,"expiration_date":"2036-07-27","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001193125-26-324256","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/949858/000119312526324256/ownership.xml","form_type":"4"}},{"id":701654,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":26548,"kind":"person","name":"Royston Aaron","position":1,"cik":"0001727703","reported_name":"Royston Aaron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit (RSU)","published_at":"2026-07-29T21:22:59.000Z","date":"2026-07-27","kind":"grant","planned":false,"acquired":true,"shares":16700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock at settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the terms of the RSU, the shares underlying the RSU vest 100% on the earlier of July 27, 2027 or the date immediately prior to the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's provision of service to the Issuer on the vesting date."}],"balance_after":16700,"derivative":{"expiration_date":"2036-07-27","underlying":"Common Stock","underlying_shares":16700},"source":{"system":"sec-edgar","filing":"0001193125-26-324253","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/949858/000119312526324253/ownership.xml","form_type":"4"}},{"id":701653,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":26548,"kind":"person","name":"Royston Aaron","position":1,"cik":"0001727703","reported_name":"Royston Aaron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-07-29T21:22:59.000Z","date":"2026-07-27","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest 100% on the earlier of July 27, 2027 or the date immediately prior to the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's provision of service to the Issuer on the vesting date."}],"balance_after":25000,"derivative":{"exercise_price":6.18,"expiration_date":"2036-07-27","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001193125-26-324253","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/949858/000119312526324253/ownership.xml","form_type":"4"}},{"id":701650,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":22001,"kind":"person","name":"Waldman Reid Alexander","position":1,"cik":"0002107415","reported_name":"Waldman Reid Alexander","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit (RSU)","published_at":"2026-07-29T21:21:57.000Z","date":"2026-07-27","kind":"grant","planned":false,"acquired":true,"shares":16700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock at settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the terms of the RSU, the shares underlying the RSU vest 100% on the earlier of July 27, 2027 or the date immediately prior to the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's provision of service to the Issuer on the vesting date."}],"balance_after":16700,"derivative":{"expiration_date":"2036-07-27","underlying":"Common Stock","underlying_shares":16700},"source":{"system":"sec-edgar","filing":"0001193125-26-324250","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/949858/000119312526324250/ownership.xml","form_type":"4"}},{"id":701649,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":22001,"kind":"person","name":"Waldman Reid Alexander","position":1,"cik":"0002107415","reported_name":"Waldman Reid Alexander","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-07-29T21:21:57.000Z","date":"2026-07-27","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest 100% on the earlier of July 27, 2027 or the date immediately prior to the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's provision of service to the Issuer on the vesting date."}],"balance_after":25000,"derivative":{"exercise_price":6.18,"expiration_date":"2036-07-27","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001193125-26-324250","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/949858/000119312526324250/ownership.xml","form_type":"4"}},{"id":701646,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":21010,"kind":"person","name":"Stewart Richard Alistair","position":1,"cik":"0001713369","reported_name":"Stewart Richard Alistair","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit (RSU)","published_at":"2026-07-29T21:20:24.000Z","date":"2026-07-27","kind":"grant","planned":false,"acquired":true,"shares":16700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock at settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the terms of the RSU, the shares underlying the RSU vest 100% on the earlier of July 27, 2027 or the date immediately prior to the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's provision of service to the Issuer on the vesting date."}],"balance_after":16700,"derivative":{"expiration_date":"2036-07-27","underlying":"Common Stock","underlying_shares":16700},"source":{"system":"sec-edgar","filing":"0001193125-26-324245","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/949858/000119312526324245/ownership.xml","form_type":"4"}},{"id":701645,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":21010,"kind":"person","name":"Stewart Richard Alistair","position":1,"cik":"0001713369","reported_name":"Stewart Richard Alistair","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-07-29T21:20:24.000Z","date":"2026-07-27","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest 100% on the earlier of July 27, 2027 or the date immediately prior to the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's provision of service to the Issuer on the vesting date."}],"balance_after":25000,"derivative":{"exercise_price":6.18,"expiration_date":"2036-07-27","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001193125-26-324245","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/949858/000119312526324245/ownership.xml","form_type":"4"}},{"id":701648,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":28092,"kind":"person","name":"Farrow Jeffrey S","position":1,"cik":"0001405253","reported_name":"Farrow Jeffrey S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit (RSU)","published_at":"2026-07-29T21:19:05.000Z","date":"2026-07-27","kind":"grant","planned":false,"acquired":true,"shares":16700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock at settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the terms of the RSU, the shares underlying the RSU vest 100% on the earlier of July 27, 2027 or the date immediately prior to the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's provision of service to the Issuer on the vesting date."}],"balance_after":16700,"derivative":{"expiration_date":"2036-07-27","underlying":"Common Stock","underlying_shares":16700},"source":{"system":"sec-edgar","filing":"0001193125-26-324238","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/949858/000119312526324238/ownership.xml","form_type":"4"}},{"id":701647,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":28092,"kind":"person","name":"Farrow Jeffrey S","position":1,"cik":"0001405253","reported_name":"Farrow Jeffrey S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-07-29T21:19:05.000Z","date":"2026-07-27","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest 100% on the earlier of July 27, 2027 or the date immediately prior to the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's provision of service to the Issuer on the vesting date."}],"balance_after":25000,"derivative":{"exercise_price":6.18,"expiration_date":"2036-07-27","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001193125-26-324238","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/949858/000119312526324238/ownership.xml","form_type":"4"}},{"id":701644,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":28091,"kind":"person","name":"Phelan Nancy R.","position":1,"cik":"0001750316","reported_name":"Phelan Nancy R.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit (RSU)","published_at":"2026-07-29T21:17:27.000Z","date":"2026-07-27","kind":"grant","planned":false,"acquired":true,"shares":16700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock at settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the terms of the RSU, the shares underlying the RSU vest 100% on the earlier of July 27, 2027 or the date immediately prior to the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's provision of service to the Issuer on the vesting date."}],"balance_after":16700,"derivative":{"expiration_date":"2036-07-27","underlying":"Common Stock","underlying_shares":16700},"source":{"system":"sec-edgar","filing":"0001193125-26-324231","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/949858/000119312526324231/ownership.xml","form_type":"4"}},{"id":701643,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":28091,"kind":"person","name":"Phelan Nancy R.","position":1,"cik":"0001750316","reported_name":"Phelan Nancy R.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-07-29T21:17:27.000Z","date":"2026-07-27","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest 100% on the earlier of July 27, 2027 or the date immediately prior to the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's provision of service to the Issuer on the vesting date."}],"balance_after":25000,"derivative":{"exercise_price":6.18,"expiration_date":"2036-07-27","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001193125-26-324231","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/949858/000119312526324231/ownership.xml","form_type":"4"}},{"id":755833,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":22001,"kind":"person","name":"Waldman Reid Alexander","position":1,"cik":"0002107415","reported_name":"Waldman Reid Alexander","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-02T20:13:36.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":47250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in substantially equal monthly installments over 36 months commencing May 29, 2026, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":47250,"derivative":{"exercise_price":5.24,"expiration_date":"2036-05-29","underlying":"Common Stock","underlying_shares":47250},"source":{"system":"sec-edgar","filing":"0002107415-26-000004","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/949858/000210741526000004/ownership.xml","form_type":"4"}},{"id":755832,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":28092,"kind":"person","name":"Farrow Jeffrey S","position":1,"cik":"0001405253","reported_name":"Farrow Jeffrey S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-02T20:12:33.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":47250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in substantially equal monthly installments over 36 months commencing May 29, 2026, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":47250,"derivative":{"exercise_price":5.24,"expiration_date":"2036-05-29","underlying":"Common Stock","underlying_shares":47250},"source":{"system":"sec-edgar","filing":"0001405253-26-000011","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/949858/000140525326000011/ownership.xml","form_type":"4"}},{"id":781460,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":28093,"kind":"person","name":"Martin Christopher Nathan","position":1,"cik":"0002097992","reported_name":"Martin Christopher Nathan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-05-13T20:35:04.000Z","date":"2026-05-11","kind":"grant","planned":false,"acquired":true,"shares":47250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in substantially equal monthly installments over 36 months commencing May 11, 2026, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":47250,"derivative":{"exercise_price":5.59,"expiration_date":"2036-05-11","underlying":"Common Stock","underlying_shares":47250},"source":{"system":"sec-edgar","filing":"0001193125-26-221774","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/949858/000119312526221774/ownership.xml","form_type":"4"}},{"id":803932,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":34851,"kind":"person","name":"Goldberg Andrew D.","position":1,"cik":"0001827722","reported_name":"Goldberg Andrew D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Performance Restricted Stock Unit (PRSU)","published_at":"2026-04-21T22:20:25.000Z","date":"2026-04-18","kind":"grant","planned":false,"acquired":true,"shares":11706270,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock at settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the terms of the award agreement governing the PRSU, the number of shares underlying the PRSU vest based on achievement of eight share price milestones ranging from 2x to 9x of a reference price, in whole or in part, upon achievement of certain financial performance conditions. The PRSUs are eligible for accelerated vesting pursuant to the Reporting Person's employment agreement with the Issuer."}],"balance_after":11706270,"derivative":{"expiration_date":"2036-04-18","underlying":"Common Stock","underlying_shares":11706270},"source":{"system":"sec-edgar","filing":"0001193125-26-167418","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/949858/000119312526167418/ownership.xml","form_type":"4"}},{"id":803931,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":34851,"kind":"person","name":"Goldberg Andrew D.","position":1,"cik":"0001827722","reported_name":"Goldberg Andrew D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Stock Option (right to buy)","published_at":"2026-04-21T22:20:25.000Z","date":"2026-04-18","kind":"grant","planned":false,"acquired":true,"shares":3601929,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option will vest as to 1/4 of the total award on the one-year anniversary of April 18, 2026, and thereafter in substantially equal monthly installments over thirty-six months, subject to the Reporting Person's provision of services to the Issuer on each vesting date.  The shares subject to the option are eligible for accelerated vesting pursuant to the Reporting Person's employment agreement with the Issuer."}],"balance_after":3601929,"derivative":{"exercise_price":4.25,"expiration_date":"2036-04-18","underlying":"Common Stock","underlying_shares":3601929},"source":{"system":"sec-edgar","filing":"0001193125-26-167418","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/949858/000119312526167418/ownership.xml","form_type":"4"}},{"id":803930,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":34851,"kind":"person","name":"Goldberg Andrew D.","position":1,"cik":"0001827722","reported_name":"Goldberg Andrew D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Restricted Stock Unit (RSU)","published_at":"2026-04-21T22:20:25.000Z","date":"2026-04-18","kind":"grant","planned":false,"acquired":true,"shares":1800965,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock at settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the award agreement governing the RSU, the number of shares underlying the RSU vest as to 1/4 of the total award on the one-year anniversary of April 18, 2026, and thereafter in substantially equal quarterly installments on the twelve quarterly anniversaries thereafter, subject to the Reporting Person's provision of services to the Issuer on each vesting date.  The RSUs are eligible for accelerated vesting pursuant to the Reporting Person's employment agreement with the Issuer."}],"balance_after":1800965,"derivative":{"expiration_date":"2036-04-18","underlying":"Common Stock","underlying_shares":1800965},"source":{"system":"sec-edgar","filing":"0001193125-26-167418","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/949858/000119312526167418/ownership.xml","form_type":"4"}},{"id":927415,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":68432,"kind":"person","name":"Rubinstein Mark Lawrence","position":1,"cik":"0002103809","reported_name":"Rubinstein Mark Lawrence","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-01-30T21:10:02.000Z","date":"2026-01-28","kind":"grant","planned":false,"acquired":true,"shares":180000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest as to 1/4 of the total award on the first anniversary of January 28, 2026, and thereafter in substantially equal monthly installments over 36 months, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":180000,"derivative":{"exercise_price":4.36,"expiration_date":"2036-01-28","underlying":"Common Stock","underlying_shares":180000},"source":{"system":"sec-edgar","filing":"0001193125-26-031806","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/949858/000119312526031806/ownership.xml","form_type":"4"}},{"id":927414,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":68431,"kind":"person","name":"Oki Mark K","position":1,"cik":"0001491847","reported_name":"Oki Mark K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-01-30T21:09:02.000Z","date":"2026-01-28","kind":"grant","planned":false,"acquired":true,"shares":180000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest as to 1/4 of the total award on the first anniversary of January 28, 2026, and thereafter in substantially equal monthly installments over 36 months, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":180000,"derivative":{"exercise_price":4.36,"expiration_date":"2036-01-28","underlying":"Common Stock","underlying_shares":180000},"source":{"system":"sec-edgar","filing":"0001193125-26-031801","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/949858/000119312526031801/ownership.xml","form_type":"4"}},{"id":927413,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":68430,"kind":"person","name":"Xinos Jaime","position":1,"cik":"0002041627","reported_name":"Xinos Jaime","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-01-30T21:08:02.000Z","date":"2026-01-28","kind":"grant","planned":false,"acquired":true,"shares":180000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest as to 1/4 of the total award on the first anniversary of January 28, 2026, and thereafter in substantially equal monthly installments over 36 months, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":180000,"derivative":{"exercise_price":4.36,"expiration_date":"2036-01-28","underlying":"Common Stock","underlying_shares":180000},"source":{"system":"sec-edgar","filing":"0001193125-26-031795","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/949858/000119312526031795/ownership.xml","form_type":"4"}},{"id":927412,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":68429,"kind":"person","name":"Donnelly Craig","position":1,"cik":"0002086790","reported_name":"Donnelly Craig","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operations Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-01-30T21:07:03.000Z","date":"2026-01-28","kind":"grant","planned":false,"acquired":true,"shares":180000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest as to 1/4 of the total award on the first anniversary of January 28, 2026, and thereafter in substantially equal monthly installments over 36 months, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":180000,"derivative":{"exercise_price":4.36,"expiration_date":"2036-01-28","underlying":"Common Stock","underlying_shares":180000},"source":{"system":"sec-edgar","filing":"0001193125-26-031790","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/949858/000119312526031790/ownership.xml","form_type":"4"}},{"id":927411,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":21010,"kind":"person","name":"Stewart Richard Alistair","position":1,"cik":"0001713369","reported_name":"Stewart Richard Alistair","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-01-30T21:06:03.000Z","date":"2026-01-28","kind":"grant","planned":false,"acquired":true,"shares":645000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest as to 1/4 of the total award on the first anniversary of January 28, 2026, and thereafter in substantially equal monthly installments over 36 months, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":645000,"derivative":{"exercise_price":4.36,"expiration_date":"2036-01-28","underlying":"Common Stock","underlying_shares":645000},"source":{"system":"sec-edgar","filing":"0001193125-26-031782","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/949858/000119312526031782/ownership.xml","form_type":"4"}},{"id":927407,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":68428,"kind":"person","name":"Wan Jerry","position":1,"cik":"0001828041","reported_name":"Wan Jerry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-01-30T21:05:03.000Z","date":"2026-01-28","kind":"grant","planned":false,"acquired":true,"shares":70300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest as to 1/4 of the total award on the first anniversary of January 28, 2026, and thereafter in substantially equal monthly installments over 36 months, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":70300,"derivative":{"exercise_price":4.36,"expiration_date":"2036-01-28","underlying":"Common Stock","underlying_shares":70300},"source":{"system":"sec-edgar","filing":"0001193125-26-031761","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/949858/000119312526031761/ownership.xml","form_type":"4"}},{"id":978176,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":72115,"kind":"person","name":"Atkisson Erik","position":1,"cik":"0001885915","reported_name":"Atkisson Erik","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-12-08T21:01:03.000Z","date":"2025-12-04","kind":"grant","planned":false,"acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest as to 1/4 of the total award on the first anniversary of October 20, 2025, and thereafter in substantially equal monthly installments over 36 months, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":250000,"derivative":{"exercise_price":4.78,"expiration_date":"2035-12-04","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001193125-25-311199","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/949858/000119312525311199/ownership.xml","form_type":"4"}},{"id":1025521,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":68429,"kind":"person","name":"Donnelly Craig","position":1,"cik":"0002086790","reported_name":"Donnelly Craig","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operations Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-10-03T20:37:53.000Z","date":"2025-10-01","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest as to 1/4 of the total award on the first anniversary of September 8, 2025, and thereafter in substantially equal monthly installments over 36 months, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":50000,"derivative":{"exercise_price":3.1,"expiration_date":"2035-10-01","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001193125-25-230324","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/949858/000119312525230324/ownership.xml","form_type":"4"}},{"id":1035050,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":68431,"kind":"person","name":"Oki Mark K","position":1,"cik":"0001491847","reported_name":"Oki Mark K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Performance Restricted Stock Unit (PRSU)","published_at":"2025-09-22T20:31:17.000Z","date":"2025-09-18","kind":"exercise","planned":false,"acquired":false,"shares":168000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Pursuant to the terms of the award agreement governing the PRSU, the total number of shares underlying the PRSU vest on the achievement of one of certain milestones."}],"balance_after":0,"derivative":{"expiration_date":"2028-12-06","underlying":"Common Stock","underlying_shares":168000},"source":{"system":"sec-edgar","filing":"0001193125-25-211404","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/949858/000119312525211404/ownership.xml","form_type":"4"}},{"id":1035049,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":68431,"kind":"person","name":"Oki Mark K","position":1,"cik":"0001491847","reported_name":"Oki Mark K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-09-22T20:31:17.000Z","date":"2025-09-18","kind":"sale","planned":false,"acquired":false,"shares":50060,"price":2.92,"value":146175.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of common stock that have been sold by the Reporting Person to satisfy income tax withholding and remittance obligations in connection with the net settlement of the PRSUs."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from  $2.83  to $3.02 per share, inclusive.  The reporting person hereby undertakes to provide to the Issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":127940,"source":{"system":"sec-edgar","filing":"0001193125-25-211404","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/949858/000119312525211404/ownership.xml","form_type":"4"}},{"id":1035048,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":68431,"kind":"person","name":"Oki Mark K","position":1,"cik":"0001491847","reported_name":"Oki Mark K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-09-22T20:31:17.000Z","date":"2025-09-18","kind":"exercise","planned":false,"acquired":true,"shares":168000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock acquired upon settlement of the performance restricted stock units (\"PRSUs\") listed in Table II."}],"balance_after":178000,"source":{"system":"sec-edgar","filing":"0001193125-25-211404","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/949858/000119312525211404/ownership.xml","form_type":"4"}},{"id":1035047,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":21010,"kind":"person","name":"Stewart Richard Alistair","position":1,"cik":"0001713369","reported_name":"Stewart Richard Alistair","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Performance Restricted Stock Unit (PRSU)","published_at":"2025-09-22T20:29:13.000Z","date":"2025-09-18","kind":"exercise","planned":false,"acquired":false,"shares":157500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Pursuant to the terms of the award agreement governing the PRSU, the total number of shares underlying the PRSU vest on the achievement of one of certain milestones."}],"balance_after":0,"derivative":{"expiration_date":"2029-01-13","underlying":"Common Stock","underlying_shares":157500},"source":{"system":"sec-edgar","filing":"0001193125-25-211392","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/949858/000119312525211392/ownership.xml","form_type":"4"}},{"id":1035046,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":21010,"kind":"person","name":"Stewart Richard Alistair","position":1,"cik":"0001713369","reported_name":"Stewart Richard Alistair","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Performance Restricted Stock Unit (PRSU)","published_at":"2025-09-22T20:29:13.000Z","date":"2025-09-18","kind":"exercise","planned":false,"acquired":false,"shares":140000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Pursuant to the terms of the award agreement governing the PRSU, the total number of shares underlying the PRSU vest on the achievement of one of certain milestones."}],"balance_after":0,"derivative":{"expiration_date":"2028-01-22","underlying":"Common Stock","underlying_shares":140000},"source":{"system":"sec-edgar","filing":"0001193125-25-211392","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/949858/000119312525211392/ownership.xml","form_type":"4"}},{"id":1035045,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":21010,"kind":"person","name":"Stewart Richard Alistair","position":1,"cik":"0001713369","reported_name":"Stewart Richard Alistair","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-09-22T20:29:13.000Z","date":"2025-09-18","kind":"sale","planned":false,"acquired":false,"shares":129501,"price":2.92,"value":378142.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of common stock that have been sold by the Reporting Person to satisfy income tax withholding and remittance obligations in connection with the net settlement of the PRSUs."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $2.83  to $3.02 per share, inclusive.  The reporting person hereby undertakes to provide to the Issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":228875,"source":{"system":"sec-edgar","filing":"0001193125-25-211392","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/949858/000119312525211392/ownership.xml","form_type":"4"}},{"id":1035044,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":21010,"kind":"person","name":"Stewart Richard Alistair","position":1,"cik":"0001713369","reported_name":"Stewart Richard Alistair","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-09-22T20:29:13.000Z","date":"2025-09-18","kind":"exercise","planned":false,"acquired":true,"shares":297500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock acquired upon settlement of the performance restricted stock units (\"PRSUs\") listed in Table II."}],"balance_after":358376,"source":{"system":"sec-edgar","filing":"0001193125-25-211392","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/949858/000119312525211392/ownership.xml","form_type":"4"}},{"id":1046272,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":68431,"kind":"person","name":"Oki Mark K","position":1,"cik":"0001491847","reported_name":"Oki Mark K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Performance Restricted Stock Unit","published_at":"2025-09-08T21:10:00.000Z","date":"2025-09-04","kind":"grant","planned":false,"acquired":false,"shares":168000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents performance restricted stock units (\"PRSUs\") previously reported on December 9, 2024 that were earned by the Reporting Person upon the achievement of certain performance criteria as certified by the Compensation Committee of the Issuer's Board of Directors."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the terms of the award agreement governing the PRSU, the total number of shares underlying the PRSU vest on the achievement of one of certain milestones."}],"balance_after":0,"derivative":{"expiration_date":"2028-12-06","underlying":"Common Stock","underlying_shares":168000},"source":{"system":"sec-edgar","filing":"0000950170-25-113606","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/949858/000095017025113606/ownership.xml","form_type":"4"}},{"id":1046271,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":21010,"kind":"person","name":"Stewart Richard Alistair","position":1,"cik":"0001713369","reported_name":"Stewart Richard Alistair","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chieve Executive Officer"}}],"security":"Performance Restricted Stock Unit","published_at":"2025-09-08T21:01:44.000Z","date":"2025-09-04","kind":"grant","planned":false,"acquired":false,"shares":157500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"Represent PRSUs previously reported on January 14, 2025 that were earned by the Reporting Person upon the achievement of certain performance criteria as certified by the Compensation Commmittee of the Issuer's Board of Directors."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the terms of the award agreement governing the PRSU, the total number of shares underlying the PRSU vest on the achievement of one of certain milestones."}],"balance_after":0,"derivative":{"expiration_date":"2029-01-13","underlying":"Common Stock","underlying_shares":157500},"source":{"system":"sec-edgar","filing":"0000950170-25-113598","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/949858/000095017025113598/ownership.xml","form_type":"4"}},{"id":1046270,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":21010,"kind":"person","name":"Stewart Richard Alistair","position":1,"cik":"0001713369","reported_name":"Stewart Richard Alistair","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chieve Executive Officer"}}],"security":"Performance Restricted Stock Unit","published_at":"2025-09-08T21:01:44.000Z","date":"2025-09-04","kind":"grant","planned":false,"acquired":false,"shares":140000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represent PRSUs previously reported on January 24, 2024 that were earned by the Reporting Person upon the achievement of certain performance criteria as certified by the Compensation Commmittee of the Issuer's Board of Directors."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the terms of the award agreement governing the PRSU, the total number of shares underlying the PRSU vest on the achievement of one of certain milestones."}],"balance_after":0,"derivative":{"expiration_date":"2028-01-22","underlying":"Common Stock","underlying_shares":140000},"source":{"system":"sec-edgar","filing":"0000950170-25-113598","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/949858/000095017025113598/ownership.xml","form_type":"4"}},{"id":1046269,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":68428,"kind":"person","name":"Wan Jerry","position":1,"cik":"0001828041","reported_name":"Wan Jerry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Performance Restricted Stock Unit (PRSU)","published_at":"2025-09-08T20:59:23.000Z","date":"2025-09-04","kind":"exercise","planned":false,"acquired":false,"shares":9600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F7","text":"Represents PRSUs previously reported on January 30, 2025 that were earned by the Reporting Person upon the achievement of certain performance criteria as certified by the Compensation Committee of the Issuer's Board of Directors."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Pursuant to the terms of the award agreement governing the PRSU, the number of underlying shares of the Issuer's common stock that may ultimately vest ranges from 0% to 100% of the number of the PRSUs initially granted, subject to certain milestones being met during the measurement period."}],"balance_after":38400,"derivative":{"expiration_date":"2035-01-28","underlying":"Common Stock","underlying_shares":9600},"source":{"system":"sec-edgar","filing":"0000950170-25-113592","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/949858/000095017025113592/ownership.xml","form_type":"4"}},{"id":1046268,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":68428,"kind":"person","name":"Wan Jerry","position":1,"cik":"0001828041","reported_name":"Wan Jerry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Performance Restricted Stock Unit (PRSU)","published_at":"2025-09-08T20:59:23.000Z","date":"2025-09-04","kind":"exercise","planned":false,"acquired":false,"shares":24500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"Represents PRSUs previously reported on January 24, 2024 that were earned by the Reporting Person upon the achievement of certain performance criteria as certified by the Compensation Committee of the Issuer's Board of Directors."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Pursuant to the terms of the award agreement governing the PRSU, the total number of shares underlying the PRSU vest on the achievement of one of certain milestones."}],"balance_after":0,"derivative":{"expiration_date":"2028-01-22","underlying":"Common Stock","underlying_shares":24500},"source":{"system":"sec-edgar","filing":"0000950170-25-113592","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/949858/000095017025113592/ownership.xml","form_type":"4"}},{"id":1046267,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":68428,"kind":"person","name":"Wan Jerry","position":1,"cik":"0001828041","reported_name":"Wan Jerry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2025-09-08T20:59:23.000Z","date":"2025-09-04","kind":"sale","planned":false,"acquired":false,"shares":14070,"price":2.77,"value":38973.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of common stock that have been sold by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the PRSUs."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $2.68 to $2.88 per share, inclusive.  The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":32694,"source":{"system":"sec-edgar","filing":"0000950170-25-113592","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/949858/000095017025113592/ownership.xml","form_type":"4"}},{"id":1046266,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":68428,"kind":"person","name":"Wan Jerry","position":1,"cik":"0001828041","reported_name":"Wan Jerry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2025-09-08T20:59:23.000Z","date":"2025-09-04","kind":"exercise","planned":false,"acquired":true,"shares":34100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock acquired upon settlement of the performance restricted stock units (\"PRSUs\") listed in Table II."}],"balance_after":46764,"source":{"system":"sec-edgar","filing":"0000950170-25-113592","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/949858/000095017025113592/ownership.xml","form_type":"4"}},{"id":1046261,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":75701,"kind":"person","name":"KING THOMAS BRAXTON","position":1,"cik":"0001279309","reported_name":"KING THOMAS BRAXTON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Performance Restricted Stock Unit (PRSU)","published_at":"2025-09-08T20:54:43.000Z","date":"2025-09-04","kind":"exercise","planned":false,"acquired":false,"shares":455000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"Represents PRSUs previously reported on January 14, 2025 that were earned by the Reporting Person upon the achievement of certain performance criteria as certified by the Compensation Committee of the Issuer's Board of Directors."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Pursuant to the terms of the award agreement governing the PRSU, the total number of shares underlying the PRSU vest on the achievement of one of certain milestones."}],"balance_after":0,"derivative":{"expiration_date":"2029-01-13","underlying":"Common Stock","underlying_shares":455000},"source":{"system":"sec-edgar","filing":"0000950170-25-113591","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/949858/000095017025113591/ownership.xml","form_type":"4"}},{"id":1046260,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":75701,"kind":"person","name":"KING THOMAS BRAXTON","position":1,"cik":"0001279309","reported_name":"KING THOMAS BRAXTON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-08T20:54:43.000Z","date":"2025-09-04","kind":"sale","planned":false,"acquired":false,"shares":139858,"price":2.77,"value":387406.66,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of common stock that have been sold by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the PRSUs."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $2.68 to $2.88 per share, inclusive.  The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":315142,"source":{"system":"sec-edgar","filing":"0000950170-25-113591","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/949858/000095017025113591/ownership.xml","form_type":"4"}},{"id":1046259,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":75701,"kind":"person","name":"KING THOMAS BRAXTON","position":1,"cik":"0001279309","reported_name":"KING THOMAS BRAXTON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-08T20:54:43.000Z","date":"2025-09-04","kind":"exercise","planned":false,"acquired":true,"shares":455000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock acquired upon settlement of the performance restricted stock units (\"PRSUs\") listed in Table II."}],"balance_after":455000,"source":{"system":"sec-edgar","filing":"0000950170-25-113591","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/949858/000095017025113591/ownership.xml","form_type":"4"}},{"id":1046258,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":75700,"kind":"person","name":"JACOBS CINDY","position":1,"cik":"0001229762","reported_name":"JACOBS CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CMO"}}],"security":"Performance Restricted Stock Unit (PRSU)","published_at":"2025-09-08T20:51:59.000Z","date":"2025-09-04","kind":"exercise","planned":false,"acquired":false,"shares":26000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F7","text":"Represents PRSUs previously reported on January 30, 2025 that were earned by the Reporting Person upon the achievement of certain performance criteria as certified by the Compensation Committee of the Issuer's Board of Directors."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Pursuant to the terms of the award agreement governing the PRSU, the number of underlying shares of the Issuer's common stock that may ultimately vest ranges from 0% to 100% of the number of the PRSUs initially granted, subject to certain milestones being met during the measurement period."}],"balance_after":104000,"derivative":{"expiration_date":"2035-01-28","underlying":"Common Stock","underlying_shares":26000},"source":{"system":"sec-edgar","filing":"0000950170-25-113588","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/949858/000095017025113588/ownership.xml","form_type":"4"}},{"id":1046257,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":75700,"kind":"person","name":"JACOBS CINDY","position":1,"cik":"0001229762","reported_name":"JACOBS CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CMO"}}],"security":"Performance Restricted Stock Unit (PRSU)","published_at":"2025-09-08T20:51:59.000Z","date":"2025-09-04","kind":"exercise","planned":false,"acquired":false,"shares":84000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"Represents PRSUs previously reported on January 24, 2024 that were earned by the Reporting Person upon the achievement of certain performance criteria as certified by the Compensation Committee of the Issuer's Board of Directors."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Pursuant to the terms of the award agreement governing the PRSU, the total number of shares underlying the PRSU vest on the achievement of one of certain milestones."}],"balance_after":0,"derivative":{"expiration_date":"2028-01-22","underlying":"Common Stock","underlying_shares":84000},"source":{"system":"sec-edgar","filing":"0000950170-25-113588","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/949858/000095017025113588/ownership.xml","form_type":"4"}},{"id":1046256,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":75700,"kind":"person","name":"JACOBS CINDY","position":1,"cik":"0001229762","reported_name":"JACOBS CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CMO"}}],"security":"Common Stock","published_at":"2025-09-08T20:51:59.000Z","date":"2025-09-04","kind":"sale","planned":false,"acquired":false,"shares":27629,"price":2.77,"value":76532.33,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of common stock that have been sold by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the PRSUs."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $2.68 to $2.88 per share, inclusive.  The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":115585,"source":{"system":"sec-edgar","filing":"0000950170-25-113588","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/949858/000095017025113588/ownership.xml","form_type":"4"}},{"id":1046255,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":75700,"kind":"person","name":"JACOBS CINDY","position":1,"cik":"0001229762","reported_name":"JACOBS CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CMO"}}],"security":"Common Stock","published_at":"2025-09-08T20:51:59.000Z","date":"2025-09-04","kind":"exercise","planned":false,"acquired":true,"shares":110000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock acquired upon settlement of the performance restricted stock units (\"PRSUs\") listed in Table II."}],"balance_after":143214,"source":{"system":"sec-edgar","filing":"0000950170-25-113588","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/949858/000095017025113588/ownership.xml","form_type":"4"}},{"id":1046265,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":68430,"kind":"person","name":"Xinos Jaime","position":1,"cik":"0002041627","reported_name":"Xinos Jaime","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Performance Restricted Stock Unit (PRSU)","published_at":"2025-09-08T20:39:40.000Z","date":"2025-09-04","kind":"exercise","planned":false,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F6","text":"Represents PRSUs previously reported on January 30, 2025 that were earned by the Reporting Person upon the achievement of certain performance criteria as certified by the Compensation Committee of the Issuer's Board of Directors."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Pursuant to the terms of the award agreement governing the PRSU, the number of underlying shares of the Issuer's common stock that may ultimately vest ranges from 0% to 100% of the number of the PRSUs initially granted, subject to certain milestones being met during the measurement period."}],"balance_after":80000,"derivative":{"expiration_date":"2035-01-28","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000950170-25-113581","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/949858/000095017025113581/ownership.xml","form_type":"4"}},{"id":1046264,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":68430,"kind":"person","name":"Xinos Jaime","position":1,"cik":"0002041627","reported_name":"Xinos Jaime","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Performance Restricted Stock Unit (PRSU)","published_at":"2025-09-08T20:39:40.000Z","date":"2025-09-04","kind":"exercise","planned":false,"acquired":false,"shares":49000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Pursuant to the terms of the award agreement governing the PRSU, the total number of shares underlying the PRSU vest on the achievement of one of certain milestones."}],"balance_after":0,"derivative":{"expiration_date":"2028-01-22","underlying":"Common Stock","underlying_shares":49000},"source":{"system":"sec-edgar","filing":"0000950170-25-113581","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/949858/000095017025113581/ownership.xml","form_type":"4"}},{"id":1046263,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":68430,"kind":"person","name":"Xinos Jaime","position":1,"cik":"0002041627","reported_name":"Xinos Jaime","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-09-08T20:39:40.000Z","date":"2025-09-04","kind":"sale","planned":false,"acquired":false,"shares":20854,"price":2.77,"value":57765.58,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of common stock that have been sold by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the PRSUs."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $2.68 to $2.88 per share, inclusive.  The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":74432,"source":{"system":"sec-edgar","filing":"0000950170-25-113581","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/949858/000095017025113581/ownership.xml","form_type":"4"}},{"id":1046262,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":68430,"kind":"person","name":"Xinos Jaime","position":1,"cik":"0002041627","reported_name":"Xinos Jaime","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-09-08T20:39:40.000Z","date":"2025-09-04","kind":"exercise","planned":false,"acquired":true,"shares":69000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock acquired upon settlement of the performance restricted stock units (\"PRSUs\") listed in Table II."}],"balance_after":95286,"source":{"system":"sec-edgar","filing":"0000950170-25-113581","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/949858/000095017025113581/ownership.xml","form_type":"4"}},{"id":1116880,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":78690,"kind":"person","name":"Slaoui Kristen B.","position":1,"cik":"0002050928","reported_name":"Slaoui Kristen B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-10T21:01:26.000Z","date":"2025-06-06","kind":"grant","planned":false,"acquired":true,"shares":31500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest 100% on the earlier of June 6, 2026 or the date immediately prior to the Issuer's 2026 annual meeting of stockholders."}],"balance_after":31500,"derivative":{"exercise_price":3.83,"expiration_date":"2035-06-06","underlying":"Common Stock","underlying_shares":31500},"source":{"system":"sec-edgar","filing":"0000950170-25-084439","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/949858/000095017025084439/ownership.xml","form_type":"4"}},{"id":1116879,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":28091,"kind":"person","name":"Phelan Nancy R.","position":1,"cik":"0001750316","reported_name":"Phelan Nancy R.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-10T20:58:23.000Z","date":"2025-06-06","kind":"grant","planned":false,"acquired":true,"shares":31500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest 100% on the earlier of June 6, 2026 or the date immediately prior to the Issuer's 2026 annual meeting of stockholders."}],"balance_after":31500,"derivative":{"exercise_price":3.83,"expiration_date":"2035-06-06","underlying":"Common Stock","underlying_shares":31500},"source":{"system":"sec-edgar","filing":"0000950170-25-084427","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/949858/000095017025084427/ownership.xml","form_type":"4"}},{"id":1116878,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":28095,"kind":"person","name":"Sellig Thomas","position":1,"cik":"0001969416","reported_name":"Sellig Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-10T20:55:20.000Z","date":"2025-06-06","kind":"grant","planned":false,"acquired":true,"shares":31500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest 100% on the earlier of June 6, 2026 or the date immediately prior to the Issuer's 2026 annual meeting of stockholders."}],"balance_after":31500,"derivative":{"exercise_price":3.83,"expiration_date":"2035-06-06","underlying":"Common Stock","underlying_shares":31500},"source":{"system":"sec-edgar","filing":"0000950170-25-084423","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/949858/000095017025084423/ownership.xml","form_type":"4"}},{"id":1116877,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":34837,"kind":"person","name":"Martell Bridget A","position":1,"cik":"0001629627","reported_name":"Martell Bridget A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-10T20:51:49.000Z","date":"2025-06-06","kind":"grant","planned":false,"acquired":true,"shares":31500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest 100% on the earlier of June 6, 2026 or the date immediately prior to the Issuer's 2026 annual meeting of stockholders."}],"balance_after":31500,"derivative":{"exercise_price":3.83,"expiration_date":"2035-06-06","underlying":"Common Stock","underlying_shares":31500},"source":{"system":"sec-edgar","filing":"0000950170-25-084420","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/949858/000095017025084420/ownership.xml","form_type":"4"}},{"id":1116873,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":75701,"kind":"person","name":"KING THOMAS BRAXTON","position":1,"cik":"0001279309","reported_name":"KING THOMAS BRAXTON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-10T20:48:51.000Z","date":"2025-06-06","kind":"grant","planned":false,"acquired":true,"shares":31500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest 100% on the earlier of June 6, 2026 or the date immediately prior to the Issuer's 2026 annual meeting of stockholders."}],"balance_after":31500,"derivative":{"exercise_price":3.83,"expiration_date":"2035-06-06","underlying":"Common Stock","underlying_shares":31500},"source":{"system":"sec-edgar","filing":"0000950170-25-084415","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/949858/000095017025084415/ownership.xml","form_type":"4"}},{"id":1116876,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":35319,"kind":"person","name":"Duty Stuart","position":1,"cik":"0001970274","reported_name":"Duty Stuart","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-10T20:45:24.000Z","date":"2025-06-06","kind":"grant","planned":false,"acquired":true,"shares":31500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest 100% on the earlier of June 6, 2026 or the date immediately prior to the Issuer's 2026 annual meeting of stockholders."}],"balance_after":31500,"derivative":{"exercise_price":3.83,"expiration_date":"2035-06-06","underlying":"Common Stock","underlying_shares":31500},"source":{"system":"sec-edgar","filing":"0000950170-25-084407","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/949858/000095017025084407/ownership.xml","form_type":"4"}},{"id":1197596,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":68431,"kind":"person","name":"Oki Mark K","position":1,"cik":"0001491847","reported_name":"Oki Mark K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-03-19T20:38:43.000Z","date":"2025-03-17","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":2.8887,"value":28887.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $2.85 to $2.9387 per share, inclusive.  The Rreporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0000950170-25-042074","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/949858/000095017025042074/ownership.xml","form_type":"4"}},{"id":1197595,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":21010,"kind":"person","name":"Stewart Richard Alistair","position":1,"cik":"0001713369","reported_name":"Stewart Richard Alistair","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chieve Executive Officer"}}],"security":"Common Stock","published_at":"2025-03-19T20:32:22.000Z","date":"2025-03-17","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":2.8598,"value":28598.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"In January 2025, pursuant to an agreement between the Reporting Person and the Issuer, the Reporting Person relinquished the stock option to purchase 67,500 shares of the Issuer's common stock granted on January 13, 2025."}],"balance_after":60876,"source":{"system":"sec-edgar","filing":"0000950170-25-042060","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/949858/000095017025042060/ownership.xml","form_type":"4"}},{"id":1291151,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":68428,"kind":"person","name":"Wan Jerry","position":1,"cik":"0001828041","reported_name":"Wan Jerry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Performance Restricted Stock Unit (PRSU)","published_at":"2025-01-30T21:54:30.000Z","date":"2025-01-28","kind":"grant","planned":false,"acquired":true,"shares":48000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the award agreement governing the PRSU, the number of underlying shares of the Issuer's common stock that may ultimately vest range from 0% to 100% of the number of the PRSUs initially granted, subject to certain milestones being met during the measurement period."}],"balance_after":48000,"derivative":{"expiration_date":"2035-01-28","underlying":"Common Stock","underlying_shares":48000},"source":{"system":"sec-edgar","filing":"0000950170-25-011164","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/949858/000095017025011164/ownership.xml","form_type":"4"}},{"id":1291149,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":68430,"kind":"person","name":"Xinos Jaime","position":1,"cik":"0002041627","reported_name":"Xinos Jaime","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Performance Restricted Stock Unit (PRSU)","published_at":"2025-01-30T21:51:52.000Z","date":"2025-01-28","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the award agreement governing the PRSU, the number of underlying shares of the Issuer's common stock that may ultimately vest range from 0% to 100% of the number of the PRSUs initially granted, subject to certain milestones being met during the measurement period."}],"balance_after":100000,"derivative":{"expiration_date":"2035-01-28","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000950170-25-011159","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/949858/000095017025011159/ownership.xml","form_type":"4"}},{"id":1291150,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":75700,"kind":"person","name":"JACOBS CINDY","position":1,"cik":"0001229762","reported_name":"JACOBS CINDY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CMO"}}],"security":"Performance Restricted Stock Unit (PRSU)","published_at":"2025-01-30T21:50:19.000Z","date":"2025-01-28","kind":"grant","planned":false,"acquired":true,"shares":130000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the award agreement governing the PRSU, the number of underlying shares of the Issuer's common stock that may ultimately vest range from 0% to 100% of the number of the PRSUs initially granted, subject to certain milestones being met during the measurement period."}],"balance_after":130000,"derivative":{"expiration_date":"2035-01-28","underlying":"Common Stock","underlying_shares":130000},"source":{"system":"sec-edgar","filing":"0000950170-25-011156","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/949858/000095017025011156/ownership.xml","form_type":"4"}},{"id":1303884,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":78690,"kind":"person","name":"Slaoui Kristen B.","position":1,"cik":"0002050928","reported_name":"Slaoui Kristen B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-01-14T21:46:51.000Z","date":"2025-01-13","kind":"grant","planned":false,"acquired":true,"shares":47250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in substantially equal monthly installments over 36 months commencing January 6, 2025, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":47250,"derivative":{"exercise_price":3.32,"expiration_date":"2035-01-13","underlying":"Common Stock","underlying_shares":47250},"source":{"system":"sec-edgar","filing":"0000950170-25-005405","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/949858/000095017025005405/ownership.xml","form_type":"4"}},{"id":1303883,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":28091,"kind":"person","name":"Phelan Nancy R.","position":1,"cik":"0001750316","reported_name":"Phelan Nancy R.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-01-14T21:46:33.000Z","date":"2025-01-13","kind":"grant","planned":false,"acquired":true,"shares":47250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in substantially equal monthly installments over 36 months commencing January 6, 2025, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":47250,"derivative":{"exercise_price":3.32,"expiration_date":"2035-01-13","underlying":"Common Stock","underlying_shares":47250},"source":{"system":"sec-edgar","filing":"0000950170-25-005404","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/949858/000095017025005404/ownership.xml","form_type":"4"}},{"id":1303882,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":21010,"kind":"person","name":"Stewart Richard Alistair","position":1,"cik":"0001713369","reported_name":"Stewart Richard Alistair","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chieve Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-01-14T21:43:14.000Z","date":"2025-01-13","kind":"grant","planned":false,"acquired":true,"shares":67500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option will vest as to 1/3 of the total award on the first anniversary of August 26, 2024, and thereafter in substantially equal monthly installments over 24 months, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":67500,"derivative":{"exercise_price":3.32,"expiration_date":"2035-01-13","underlying":"Common Stock","underlying_shares":67500},"source":{"system":"sec-edgar","filing":"0000950170-25-005398","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/949858/000095017025005398/ownership.xml","form_type":"4"}},{"id":1303881,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":21010,"kind":"person","name":"Stewart Richard Alistair","position":1,"cik":"0001713369","reported_name":"Stewart Richard Alistair","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chieve Executive Officer"}}],"security":"Performance Restricted Stock Unit (PRSU)","published_at":"2025-01-14T21:43:14.000Z","date":"2025-01-13","kind":"grant","planned":false,"acquired":true,"shares":157500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the award agreement governing the PRSU, the total number of shares underlying the PRSU vest on the achievement of one of certain milestones being met.  The PRSUs will lapse in full if achievement of at least one of the milestones is not met."}],"balance_after":157500,"derivative":{"expiration_date":"2029-01-13","underlying":"Common Stock","underlying_shares":157500},"source":{"system":"sec-edgar","filing":"0000950170-25-005398","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/949858/000095017025005398/ownership.xml","form_type":"4"}},{"id":1303879,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":75701,"kind":"person","name":"KING THOMAS BRAXTON","position":1,"cik":"0001279309","reported_name":"KING THOMAS BRAXTON","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Stock Option (right to buy)","published_at":"2025-01-14T21:42:01.000Z","date":"2025-01-13","kind":"grant","planned":false,"acquired":true,"shares":195000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option will vest as to 1/4 of the total award on the first anniversary of August 26, 2024, and thereafter in substantially equal monthly installments over 36 months, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":195000,"derivative":{"exercise_price":3.32,"expiration_date":"2035-01-13","underlying":"Common Stock","underlying_shares":195000},"source":{"system":"sec-edgar","filing":"0000950170-25-005392","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/949858/000095017025005392/ownership.xml","form_type":"4"}},{"id":1303878,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":75701,"kind":"person","name":"KING THOMAS BRAXTON","position":1,"cik":"0001279309","reported_name":"KING THOMAS BRAXTON","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Performance Restricted Stock Unit (PRSU)","published_at":"2025-01-14T21:42:01.000Z","date":"2025-01-13","kind":"grant","planned":false,"acquired":true,"shares":455000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the award agreement governing the PRSU, the total number of shares underlying the PRSU vest on the achievement of one of certain milestones being met.  The PRSUs will lapse in full if achievement of at least one of the milestones is not met."}],"balance_after":455000,"derivative":{"expiration_date":"2029-01-13","underlying":"Common Stock","underlying_shares":455000},"source":{"system":"sec-edgar","filing":"0000950170-25-005392","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/949858/000095017025005392/ownership.xml","form_type":"4"}},{"id":1303880,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":68430,"kind":"person","name":"Xinos Jaime","position":1,"cik":"0002041627","reported_name":"Xinos Jaime","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-01-14T21:41:09.000Z","date":"2025-01-13","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest as to 1/4 of the total award on the first anniversary of December 6, 2024, and thereafter in substantially equal monthly installments over 36 months, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":20000,"derivative":{"exercise_price":3.32,"expiration_date":"2035-01-13","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000950170-25-005389","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/949858/000095017025005389/ownership.xml","form_type":"4"}},{"id":1339505,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":68430,"kind":"person","name":"Xinos Jaime","position":1,"cik":"0002041627","reported_name":"Xinos Jaime","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-12-09T21:45:38.000Z","date":"2024-12-06","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest 25% on the first anniversary of December 6, 2024 and thereafter in monthly installments over 36 months."}],"balance_after":30000,"derivative":{"exercise_price":4.52,"expiration_date":"2034-12-06","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000950170-24-134606","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/949858/000095017024134606/ownership.xml","form_type":"4"}},{"id":1339504,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":68431,"kind":"person","name":"Oki Mark K","position":1,"cik":"0001491847","reported_name":"Oki Mark K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Performance Restricted Stock Unit (PRSU)","published_at":"2024-12-09T21:39:27.000Z","date":"2024-12-06","kind":"grant","planned":false,"acquired":true,"shares":168000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock at settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the terms of the award agreement governing the PRSU, the total number of shares underlying the PRSU vest on the achievement of one of certain milestones being met.  The PRSUs will lapse in full if achievement of at least one of the milestones is not met."}],"balance_after":168000,"derivative":{"expiration_date":"2028-12-06","underlying":"Common Stock","underlying_shares":168000},"source":{"system":"sec-edgar","filing":"0000950170-24-134600","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/949858/000095017024134600/ownership.xml","form_type":"4"}},{"id":1339503,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":68431,"kind":"person","name":"Oki Mark K","position":1,"cik":"0001491847","reported_name":"Oki Mark K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock Options (right to buy)","published_at":"2024-12-09T21:39:27.000Z","date":"2024-12-06","kind":"grant","planned":false,"acquired":true,"shares":72000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest one-third on the first anniversay of December 5, 2024 and thereafter in monthly installments over 24 months."}],"balance_after":72000,"derivative":{"exercise_price":4.52,"expiration_date":"2034-12-06","underlying":"Common Stock","underlying_shares":72000},"source":{"system":"sec-edgar","filing":"0000950170-24-134600","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/949858/000095017024134600/ownership.xml","form_type":"4"}},{"id":1428227,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":68428,"kind":"person","name":"Wan Jerry","position":1,"cik":"0001828041","reported_name":"Wan Jerry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2024-08-20T20:11:26.000Z","date":"2024-08-16","kind":"grant","planned":false,"acquired":true,"shares":2857,"price":3.67,"value":10485.19,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock acquired under the Issuer's 2017 Employee Stock Purchase Plan (\"ESPP\")."}],"balance_after":12664,"source":{"system":"sec-edgar","filing":"0000950170-24-099091","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/949858/000095017024099091/ownership.xml","form_type":"4"}},{"id":1428224,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":75700,"kind":"person","name":"JACOBS CINDY","position":1,"cik":"0001229762","reported_name":"JACOBS CINDY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CMO"}}],"security":"Common Stock","published_at":"2024-08-20T20:07:58.000Z","date":"2024-08-16","kind":"grant","planned":false,"acquired":true,"shares":2660,"price":3.67,"value":9762.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock acquired under the Issuer's 2017 Employee Stock Purchase Plan."}],"balance_after":33214,"source":{"system":"sec-edgar","filing":"0000950170-24-099082","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/949858/000095017024099082/ownership.xml","form_type":"4"}},{"id":1428223,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":53826,"kind":"person","name":"Bencich John","position":1,"cik":"0001477056","reported_name":"Bencich John","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2024-08-20T20:05:33.000Z","date":"2024-08-16","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":3.67,"value":18350.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock acquired under the Issuer's 2017 Employee Stock Purchase Plan."}],"balance_after":100636,"source":{"system":"sec-edgar","filing":"0000950170-24-099074","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/949858/000095017024099074/ownership.xml","form_type":"4"}},{"id":1537098,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":68428,"kind":"person","name":"Wan Jerry","position":1,"cik":"0001828041","reported_name":"Wan Jerry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Performance Restricted Stock Unit (PRSU)","published_at":"2024-04-23T20:39:09.000Z","date":"2024-04-19","kind":"exercise","planned":false,"acquired":false,"shares":5625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the terms of the PRSU 50% of the total shares underlying the PRSU vest on the achievement of a performance-based milestone, and 50% vest on the first anniversary of the achievement of such milestone."}],"balance_after":0,"derivative":{"expiration_date":"2026-01-03","underlying":"Common Stock","underlying_shares":5625},"source":{"system":"sec-edgar","filing":"0000950170-24-046984","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/949858/000095017024046984/ownership.xml","form_type":"4"}},{"id":1537097,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":68428,"kind":"person","name":"Wan Jerry","position":1,"cik":"0001828041","reported_name":"Wan Jerry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2024-04-23T20:39:09.000Z","date":"2024-04-19","kind":"tax_withholding","planned":false,"acquired":false,"shares":2250,"price":4.51,"value":10147.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of common stock that have been withheld by the issuer to satisfy the tax liability in connection with the settlement of PRSUs."}],"balance_after":9807,"source":{"system":"sec-edgar","filing":"0000950170-24-046984","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/949858/000095017024046984/ownership.xml","form_type":"4"}},{"id":1537096,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":68428,"kind":"person","name":"Wan Jerry","position":1,"cik":"0001828041","reported_name":"Wan Jerry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2024-04-23T20:39:09.000Z","date":"2024-04-19","kind":"exercise","planned":false,"acquired":true,"shares":5625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock acquired upon settlement of the performance restricted stock units (\"PRSUs\") listed in Table II."}],"balance_after":12057,"source":{"system":"sec-edgar","filing":"0000950170-24-046984","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/949858/000095017024046984/ownership.xml","form_type":"4"}},{"id":1537095,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":75700,"kind":"person","name":"JACOBS CINDY","position":1,"cik":"0001229762","reported_name":"JACOBS CINDY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CMO"}}],"security":"Performance Restricted Stock Unit (PRSU)","published_at":"2024-04-23T20:35:12.000Z","date":"2024-04-19","kind":"exercise","planned":false,"acquired":false,"shares":16250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the terms of the PRSU 50% of the total shares underlying the PRSU vest on the achievement of a performance-based milestone, and 50% vest on the first anniversary of the achievement of such milestone."}],"balance_after":0,"derivative":{"expiration_date":"2026-01-03","underlying":"Common Stock","underlying_shares":16250},"source":{"system":"sec-edgar","filing":"0000950170-24-046974","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/949858/000095017024046974/ownership.xml","form_type":"4"}},{"id":1537094,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":75700,"kind":"person","name":"JACOBS CINDY","position":1,"cik":"0001229762","reported_name":"JACOBS CINDY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CMO"}}],"security":"Common Stock","published_at":"2024-04-23T20:35:12.000Z","date":"2024-04-19","kind":"tax_withholding","planned":false,"acquired":false,"shares":3957,"price":4.51,"value":17846.07,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of common stock that have been withheld by the issuer to satisfy the tax liability in connection with the settlement of PRSUs."}],"balance_after":30554,"source":{"system":"sec-edgar","filing":"0000950170-24-046974","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/949858/000095017024046974/ownership.xml","form_type":"4"}},{"id":1537093,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":75700,"kind":"person","name":"JACOBS CINDY","position":1,"cik":"0001229762","reported_name":"JACOBS CINDY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CMO"}}],"security":"Common Stock","published_at":"2024-04-23T20:35:12.000Z","date":"2024-04-19","kind":"exercise","planned":false,"acquired":true,"shares":16250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock acquired upon settlement of the performance restricted stock units (\"PRSUs\") listed in Table II."}],"balance_after":34511,"source":{"system":"sec-edgar","filing":"0000950170-24-046974","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/949858/000095017024046974/ownership.xml","form_type":"4"}},{"id":1537092,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":21010,"kind":"person","name":"Stewart Richard Alistair","position":1,"cik":"0001713369","reported_name":"Stewart Richard Alistair","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Performance Restricted Stock Unit (PRSU)","published_at":"2024-04-23T20:31:40.000Z","date":"2024-04-19","kind":"exercise","planned":false,"acquired":false,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the terms of the PRSU 50% of the total shares underlying the PRSU vest on the achievement of a performance-based milestone, and 50% vest on the first anniversary of the achievement of such milestone."}],"balance_after":0,"derivative":{"expiration_date":"2026-01-03","underlying":"Common Stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0000950170-24-046962","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/949858/000095017024046962/ownership.xml","form_type":"4"}},{"id":1537091,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":21010,"kind":"person","name":"Stewart Richard Alistair","position":1,"cik":"0001713369","reported_name":"Stewart Richard Alistair","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2024-04-23T20:31:40.000Z","date":"2024-04-19","kind":"tax_withholding","planned":false,"acquired":false,"shares":10125,"price":4.51,"value":45663.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of common stock that have been withheld by the issuer to satisfy the tax liability in connection with the settlement of PRSUs."}],"balance_after":50876,"source":{"system":"sec-edgar","filing":"0000950170-24-046962","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/949858/000095017024046962/ownership.xml","form_type":"4"}},{"id":1537090,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":21010,"kind":"person","name":"Stewart Richard Alistair","position":1,"cik":"0001713369","reported_name":"Stewart Richard Alistair","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2024-04-23T20:31:40.000Z","date":"2024-04-19","kind":"exercise","planned":false,"acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock acquired upon settlement of the performance restricted stock units (\"PRSUs\") listed in Table II."}],"balance_after":61001,"source":{"system":"sec-edgar","filing":"0000950170-24-046962","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/949858/000095017024046962/ownership.xml","form_type":"4"}},{"id":1537089,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":53826,"kind":"person","name":"Bencich John","position":1,"cik":"0001477056","reported_name":"Bencich John","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Performance Restricted Stock Unit (PRSU)","published_at":"2024-04-23T20:26:56.000Z","date":"2024-04-19","kind":"exercise","planned":false,"acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the terms of the PRSU 50% of the total shares underlying the PRSU vest on the achievement of a performance-based milestone, and 50% vest on the first anniversary of the achievement of such milestone."}],"balance_after":0,"derivative":{"expiration_date":"2026-01-03","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000950170-24-046936","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/949858/000095017024046936/ownership.xml","form_type":"4"}},{"id":1537088,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":53826,"kind":"person","name":"Bencich John","position":1,"cik":"0001477056","reported_name":"Bencich John","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2024-04-23T20:26:56.000Z","date":"2024-04-19","kind":"tax_withholding","planned":false,"acquired":false,"shares":6088,"price":4.51,"value":27456.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of common stock that have been withheld by the issuer to satisfy the tax liability in connection with the settlement of PRSUs."}],"balance_after":95636,"source":{"system":"sec-edgar","filing":"0000950170-24-046936","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/949858/000095017024046936/ownership.xml","form_type":"4"}},{"id":1537087,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":53826,"kind":"person","name":"Bencich John","position":1,"cik":"0001477056","reported_name":"Bencich John","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2024-04-23T20:26:56.000Z","date":"2024-04-19","kind":"exercise","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock acquired upon settlement of the performance restricted stock units (\"PRSUs\") listed in Table II."}],"balance_after":101724,"source":{"system":"sec-edgar","filing":"0000950170-24-046936","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/949858/000095017024046936/ownership.xml","form_type":"4"}},{"id":1592661,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":21010,"kind":"person","name":"Stewart Richard Alistair","position":1,"cik":"0001713369","reported_name":"Stewart Richard Alistair","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock Warrants (right to buy)","published_at":"2024-03-06T21:49:23.000Z","date":"2024-03-04","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The common shares reported on this Form 4 were purchased in a registered direct offering (the \"RDO\") at a price of $4.585, for an aggregate purchase price of $45,850 pursuant to a Securities Purchase Agreement (the \"SPA\") dated February 28, 2024. The SPA also provides for a concurrent private placement of warrants to purchase common shares (the \"Private Placement Warrants\") .  The Private Placement Warrants are exercisable immediately upon issuance until the earlier of (x) three and one-half years after the date of issuance, and (y) 30 days following the Issuer's public disclosure of the acceptance of an NDA for cytisinicline by the FDA in a Day 74 Letter or equivalent correspondence."}],"balance_after":10000,"derivative":{"exercise_price":4.906,"exercise_date":"2024-03-04","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000950170-24-027261","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/949858/000095017024027261/ownership.xml","form_type":"4"}},{"id":1592660,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":21010,"kind":"person","name":"Stewart Richard Alistair","position":1,"cik":"0001713369","reported_name":"Stewart Richard Alistair","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2024-03-06T21:49:23.000Z","date":"2024-03-04","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":4.585,"value":45850.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The common shares reported on this Form 4 were purchased in a registered direct offering (the \"RDO\") at a price of $4.585, for an aggregate purchase price of $45,850 pursuant to a Securities Purchase Agreement (the \"SPA\") dated February 28, 2024. The SPA also provides for a concurrent private placement of warrants to purchase common shares (the \"Private Placement Warrants\") .  The Private Placement Warrants are exercisable immediately upon issuance until the earlier of (x) three and one-half years after the date of issuance, and (y) 30 days following the Issuer's public disclosure of the acceptance of an NDA for cytisinicline by the FDA in a Day 74 Letter or equivalent correspondence."}],"balance_after":38501,"source":{"system":"sec-edgar","filing":"0000950170-24-027261","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/949858/000095017024027261/ownership.xml","form_type":"4"}},{"id":1592659,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":53826,"kind":"person","name":"Bencich John","position":1,"cik":"0001477056","reported_name":"Bencich John","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock Warrants (right to buy)","published_at":"2024-03-06T21:43:53.000Z","date":"2024-03-04","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The common shares reported on this Form 4 were purchased in a registered direct offering (the \"RDO\") at a price of $4.585, for an aggregate purchase price of $45,850 pursuant to a Securities Purchase Agreement (the \"SPA\") dated February 28, 2024. The SPA also provides for a concurrent private placement of warrants to purchase common shares (the \"Private Placement Warrants\") .  The Private Placement Warrants are exercisable immediately upon issuance until the earlier of (x) three and one-half years after the date of issuance, and (y) 30 days following the Issuer's public disclosure of the acceptance of an NDA for cytisinicline by the FDA in a Day 74 Letter or equivalent correspondence."}],"balance_after":10000,"derivative":{"exercise_price":4.906,"exercise_date":"2024-03-04","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000950170-24-027243","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/949858/000095017024027243/ownership.xml","form_type":"4"}},{"id":1592658,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":53826,"kind":"person","name":"Bencich John","position":1,"cik":"0001477056","reported_name":"Bencich John","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2024-03-06T21:43:53.000Z","date":"2024-03-04","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":4.585,"value":45850.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The common shares reported on this Form 4 were purchased in a registered direct offering (the \"RDO\") at a price of $4.585, for an aggregate purchase price of $45,850 pursuant to a Securities Purchase Agreement (the \"SPA\") dated February 28, 2024. The SPA also provides for a concurrent private placement of warrants to purchase common shares (the \"Private Placement Warrants\") .  The Private Placement Warrants are exercisable immediately upon issuance until the earlier of (x) three and one-half years after the date of issuance, and (y) 30 days following the Issuer's public disclosure of the acceptance of an NDA for cytisinicline by the FDA in a Day 74 Letter or equivalent correspondence."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number reflects a decrease of ownership of 6 shares of common stock from the number of shares previously reported due to an administrative error at the time of the Issuer's 1-for-20 split on July 31, 2020."}],"balance_after":76724,"source":{"system":"sec-edgar","filing":"0000950170-24-027243","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/949858/000095017024027243/ownership.xml","form_type":"4"}},{"id":1668492,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":34837,"kind":"person","name":"Martell Bridget A","position":1,"cik":"0001629627","reported_name":"Martell Bridget A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-01-29T19:07:33.000Z","date":"2024-01-22","kind":"grant","planned":false,"acquired":true,"shares":31500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest 100% on the earlier of 18 months from the grant date or the date immediately prior to the Issuer's 2025 annual meeting of stockholders."}],"balance_after":31500,"derivative":{"exercise_price":4.55,"expiration_date":"2034-01-22","underlying":"Common Stock","underlying_shares":31500},"source":{"system":"sec-edgar","filing":"0001209191-24-002333","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/949858/000120919124002333/doc4.xml","form_type":"4"}},{"id":1672346,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":75701,"kind":"person","name":"KING THOMAS BRAXTON","position":1,"cik":"0001279309","reported_name":"KING THOMAS BRAXTON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-01-25T00:22:40.000Z","date":"2024-01-22","kind":"grant","planned":false,"acquired":true,"shares":31500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest 100% on the earlier of 18 months from the grant date or the date immediately prior to the Issuer's 2025 annual meeting of stockholders."}],"balance_after":31500,"derivative":{"exercise_price":4.55,"expiration_date":"2034-01-22","underlying":"Common Stock","underlying_shares":31500},"source":{"system":"sec-edgar","filing":"0001209191-24-002207","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/949858/000120919124002207/doc4.xml","form_type":"4"}},{"id":1672345,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":35319,"kind":"person","name":"Duty Stuart","position":1,"cik":"0001970274","reported_name":"Duty Stuart","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-01-25T00:20:14.000Z","date":"2024-01-22","kind":"grant","planned":false,"acquired":true,"shares":31500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest 100% on the earlier of 18 months from the grant date or the date immediately prior to the Issuer's 2025 annual meeting of stockholders."}],"balance_after":31500,"derivative":{"exercise_price":4.55,"expiration_date":"2034-01-22","underlying":"Common Stock","underlying_shares":31500},"source":{"system":"sec-edgar","filing":"0001209191-24-002205","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/949858/000120919124002205/doc4.xml","form_type":"4"}},{"id":1672344,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":28095,"kind":"person","name":"Sellig Thomas","position":1,"cik":"0001969416","reported_name":"Sellig Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-01-25T00:09:36.000Z","date":"2024-01-22","kind":"grant","planned":false,"acquired":true,"shares":31500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest 100% on the earlier of 18 months from the grant date or the date immediately prior to the Issuer's 2025 annual meeting of stockholders."}],"balance_after":31500,"derivative":{"exercise_price":4.55,"expiration_date":"2034-01-22","underlying":"Common Stock","underlying_shares":31500},"source":{"system":"sec-edgar","filing":"0001209191-24-002202","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/949858/000120919124002202/doc4.xml","form_type":"4"}}],"next_cursor":"2024-01-25T00:09:36.000000Z,1672344"}